Safety and Efficacy of Intravitreal LFG316 in Wet Age Related Macular Degeneration (AMD)

Status:
Completed

Trial end date:
2013-07-01

Target enrollment:

Participant gender:

This study will assess the safety and efficacy of LFG316 in patients with age related macular degeneration.

Phase 2

Novartis Pharmaceuticals